49 reports

  • Cervical Cancer Key Statistics
  • 19.2 South Korea Cervical Cancer Mortality
  • Cervical Cancer
  • Sexually Transmitted Disease
  • Asia
  • Europe
  • Forecast
  • 4.2.3 CERVICAL CANCER/ HPV - NUMBER OF VACCINES DOSES AND FORECAST
  • CERVICAL CANCER/ HPV - FORECAST FOR NUMBER OF VACCINES DOSES (MILLION), 2016 - 2021
  • Cervical Cancer
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • CERVICAL CANCER DIAGNOSIS BY HPV TESTING
  • EARLY DETECTION OF CERVICAL CANCER TO PREVENT THE GROWING PREVALENCE
  • Cervical Cancer
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group
  • Introduction
  • Market drivers
  • Cervical Cancer
  • Endoscope
  • World
  • Forecast
  • CooperSurgical, Inc.

Key Features of the Report: - Cervical Cancer Patient Flow - Cervical Cancer Prevalence - Cervical Cancer Diagnosed Patients - Cervical Cancer Treated Patients

  • Cervical Cancer
  • Europe
  • France
  • World
  • Forecast
  • 14.2 Norway Cervical Cancer Mortality
  • 18.2 Japan Cervical Cancer Mortality
  • Cervical Cancer
  • In Vitro Diagnostics
  • Asia
  • Europe
  • Forecast
  • CERVICAL CANCER SCREENING IS A MAJOR APPLICATION OF THE HPV TESTING
  • CHANGES IN REGULATORY GUIDELINES FOR CERVICAL CANCER SCREENING ACTS A RESTRAINING FACTOR HAMPERING THE MARKET GROWTH
  • Cervical Cancer
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group
  • Management of cervical cancer
  • Risk factors for cervical cancer
  • Cervical Cancer
  • Infectious Disease
  • Vaccine
  • Hoffmann-La Roche Inc.
  • Merck & Co., Inc.
  • Cervical cancer: An overview
  • Global cervical cancer diagnostic testing market ($ billions)
  • Cervical Cancer
  • HPV Testing
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.

Cervical Cancer Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Cervical Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Cervical Cancer pipeline products,

  • Cervical Cancer
  • France
  • Germany
  • Italy
  • Market Size
  • 5.2 United States Cervical Cancer Mortality
  • 6.2 Canada Cervical Cancer Mortality
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Sexually Transmitted Disease
  • North America
  • Forecast
  • Europe Cervical Cancer Testing Market
  • 11.2 Switzerland Cervical Cancer Mortality
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Sexually Transmitted Disease
  • Europe
  • Forecast
  • 6.2 Japan Cervical Cancer Mortality
  • 7.2 Korea Cervical Cancer Mortality
  • Cervical Cancer
  • In Vitro Diagnostic Reagent
  • Mortality
  • Asia
  • Forecast

Key Features of the Report: - Cervical Cancer Patient Flow - Cervical Cancer Prevalence - Cervical Cancer Diagnosed Patients - Cervical Cancer Treated Patients

  • Cervical Cancer
  • Europe
  • France
  • Germany
  • Forecast
  • CHAPTER III CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Major Producer Facility Locations and Output
  • Cervical Cancer
  • China
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Jiangsu Hansoh Pharmaceutical Co., Ltd
  • Ltd Shanghai Richem International Co.

Cervical Cancer Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Cervical Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Cervical Cancer pipeline products,

  • Cervical Cancer
  • Europe
  • France
  • Germany
  • Market Size

Japan Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) Japan Cervical Cancer Epidemiology ##) M

  • Cancer
  • Cervical Cancer
  • Pathology
  • Japan
  • Market Size

UK Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) UK Cervical Cancer Epidemiology ##) Markete

  • Cancer
  • Cervical Cancer
  • Pathology
  • United Kingdom
  • Market Size

France Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) France Cervical Cancer Epidemiology ##)

  • Cancer
  • Cervical Cancer
  • Pathology
  • France
  • Market Size

Germany Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) Germany Cervical Cancer Epidemiology

  • Cancer
  • Cervical Cancer
  • Pathology
  • Germany
  • Market Size

Italy Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) Italy Cervical Cancer Epidemiology ##) M

  • Cancer
  • Cervical Cancer
  • Pathology
  • Italy
  • Market Size

The National Cervical Cancer Coalition, WHO, CDC, the U. S.

  • Cancer
  • Cervical Cancer
  • Pathology
  • Forecast

US Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) US Cervical Cancer Epidemiology ##) Markete

  • Cancer
  • Cervical Cancer
  • Pathology
  • Market Size

Spain Cervical Cancer Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Cervical Cancer Treatments ##) Cervical Cancer Pipeline ##) Spain Cervical Cancer Epidemiology ##) M

  • Cancer
  • Cervical Cancer
  • Pathology
  • Spain
  • Market Size
  • FIGO staging of cervical cancer.
  • Incidence of cervical cancer by country.
  • Cancer
  • Cervical Cancer
  • Pathology
  • Europe

Cervical Cancer- Epidemiology Forecast to 2023 ##.

  • Cervical Cancer
  • France
  • Germany
  • United Kingdom
  • United States

Cervical Cancer Disease Coverage Forecast and Market Analysis to 2023 CONTENTS ## EPIDEMIOLOGY: CERVICAL CANCER ## Executive Summary ## Disease Background ## Sources and Methodology ## Forecast ## Epidemiologist Insight ## Strengths and Limitations ## APPENDIX ## A

  • Cancer
  • Cervical Cancer
  • Pathology
  • Europe
  • Japan

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023 Report Introduction Cervical Cancer Disease Overview • Types of Cervical cancer • Staging of Cervical cancer • Pathophysiology • Etiology • Risk Factors Diag

  • Cervical Cancer
  • Japan
  • United Kingdom
  • United States
  • Market Size

Cervical Cancer- Epidemiology Insights to 2023 Introduction Disease Overview Types of Cervical cancer Staging of Cervical cancer Pathophysiology Etiology Risk Factors Diagnosis Epidemiology and Patient Population United States Assumptions and Rat

  • Cervical Cancer
  • France
  • Germany
  • United Kingdom
  • United States

Market Spotlight: Cervical Cancer ## KEY TAKEAWAYS ## DISEASE BACKGROUND ## TREATMENT ## Surgery ## Radiotherapy ## Chemotherapy ## Targeted therapy ## EPIDEMIOLOGY ## MARKETED DRUGS ## Approvals by country ## PIPELINE DRUGS ## KEY UPCOMING EVENTS ## LICENSING AND ASSET ACQUISITION DEALS ##

  • Cancer
  • Cervical Cancer
  • Pathology
  • Forecast